vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and FITLIFE BRANDS, INC. (FTLF). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $25.9M, roughly 1.2× FITLIFE BRANDS, INC.). FITLIFE BRANDS, INC. runs the higher net margin — 6.3% vs -438.1%, a 444.4% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 72.6%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 25.1%).
FitLife Brands, Inc. is a health and wellness firm developing, marketing and distributing premium nutritional supplements, sports nutrition products and weight management solutions. It serves North American fitness enthusiasts, athletes and health-focused consumers via retail and e-commerce channels.
DOMH vs FTLF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $25.9M |
| Net Profit | $-131.8M | $1.6M |
| Gross Margin | — | 34.5% |
| Operating Margin | -8.9% | 8.8% |
| Net Margin | -438.1% | 6.3% |
| Revenue YoY | 220.4% | 72.6% |
| Net Profit YoY | -12426.2% | -20.8% |
| EPS (diluted) | $-6.94 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $25.9M | ||
| Q3 25 | $50.8M | $23.5M | ||
| Q2 25 | $34.1M | $16.1M | ||
| Q1 25 | $8.1M | $15.9M | ||
| Q4 24 | $9.4M | $15.0M | ||
| Q3 24 | $4.0M | $16.0M | ||
| Q2 24 | $6.2M | $16.9M | ||
| Q1 24 | $1.4M | $16.5M |
| Q4 25 | $-131.8M | $1.6M | ||
| Q3 25 | $125.2M | $921.0K | ||
| Q2 25 | $16.6M | $1.7M | ||
| Q1 25 | $-32.5M | $2.0M | ||
| Q4 24 | $1.1M | $2.1M | ||
| Q3 24 | $-4.2M | $2.1M | ||
| Q2 24 | $-6.1M | $2.6M | ||
| Q1 24 | $-5.4M | $2.2M |
| Q4 25 | — | 34.5% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 42.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | — | 43.8% | ||
| Q2 24 | — | 44.8% | ||
| Q1 24 | — | 44.0% |
| Q4 25 | -8.9% | 8.8% | ||
| Q3 25 | -3.1% | 9.9% | ||
| Q2 25 | -57.0% | 15.6% | ||
| Q1 25 | -394.6% | 18.6% | ||
| Q4 24 | 0.4% | 19.2% | ||
| Q3 24 | -79.1% | 19.9% | ||
| Q2 24 | -44.3% | 21.7% | ||
| Q1 24 | -205.2% | 20.4% |
| Q4 25 | -438.1% | 6.3% | ||
| Q3 25 | 246.4% | 3.9% | ||
| Q2 25 | 48.7% | 10.8% | ||
| Q1 25 | -400.5% | 12.7% | ||
| Q4 24 | 11.4% | 13.8% | ||
| Q3 24 | -104.2% | 13.3% | ||
| Q2 24 | -99.1% | 15.5% | ||
| Q1 24 | -398.0% | 13.1% |
| Q4 25 | $-6.94 | $0.16 | ||
| Q3 25 | $7.27 | $0.09 | ||
| Q2 25 | $1.12 | $0.18 | ||
| Q1 25 | $-3.02 | $0.20 | ||
| Q4 24 | $0.21 | $0.22 | ||
| Q3 24 | $-0.67 | $0.21 | ||
| Q2 24 | $-1.01 | $0.27 | ||
| Q1 24 | $-0.91 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $43.6M |
| Total Assets | $112.9M | $106.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | — | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $46.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $16.5M |
| Q4 25 | $69.4M | $43.6M | ||
| Q3 25 | $210.2M | $41.9M | ||
| Q2 25 | $88.6M | $40.9M | ||
| Q1 25 | $42.4M | $38.9M | ||
| Q4 24 | $39.9M | $36.1M | ||
| Q3 24 | $38.3M | $34.2M | ||
| Q2 24 | $42.4M | $31.9M | ||
| Q1 24 | $47.7M | $29.4M |
| Q4 25 | $112.9M | $106.3M | ||
| Q3 25 | $223.4M | $110.0M | ||
| Q2 25 | $109.3M | $62.8M | ||
| Q1 25 | $52.3M | $62.2M | ||
| Q4 24 | $47.1M | $58.5M | ||
| Q3 24 | $43.4M | $58.6M | ||
| Q2 24 | $49.1M | $57.3M | ||
| Q1 24 | $52.2M | $55.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.11× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $244.0K |
| Free Cash FlowOCF − Capex | — | $239.0K |
| FCF MarginFCF / Revenue | — | 0.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $244.0K | ||
| Q3 25 | $-4.9M | $3.7M | ||
| Q2 25 | $-353.0K | $1.2M | ||
| Q1 25 | $1.2M | $2.3M | ||
| Q4 24 | $-16.7M | $957.0K | ||
| Q3 24 | $-4.7M | $2.0M | ||
| Q2 24 | $1.4M | $1.6M | ||
| Q1 24 | $-8.6M | $5.0M |
| Q4 25 | — | $239.0K | ||
| Q3 25 | — | $3.7M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.0M |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 15.6% | ||
| Q2 25 | — | 7.4% | ||
| Q1 25 | — | 14.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 30.4% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | 0.15× | ||
| Q3 25 | -0.04× | 3.99× | ||
| Q2 25 | -0.02× | 0.68× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | -15.65× | 0.46× | ||
| Q3 24 | — | 0.96× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 2.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
FTLF
| US | $24.3M | 94% |
| Other | $1.7M | 6% |
